Published in Blood on December 01, 1995
Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation. J Biol Chem (2010) 1.36
HDL: bridging past and present with a look at the future. FASEB J (2008) 1.29
Regulation of eosinophil adhesion by lysophosphatidylcholine via a non-store-operated Ca2+ channel. Am J Respir Cell Mol Biol (2007) 0.84
Interactions of PLA2-s from Vipera lebetina, Vipera berus berus and Naja naja oxiana venom with platelets, bacterial and cancer cells. Toxins (Basel) (2013) 0.80
The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis? Vasc Health Risk Manag (2008) 0.80
Human group II 14 kDa phospholipase A2 activates human platelets. Biochem J (1997) 0.79
Stimulatory and inhibitory actions of lysophosphatidylcholine, depending on its fatty acid residue, on the phospholipase C/Ca2+ system in HL-60 leukaemia cells. Biochem J (1998) 0.76
Immune thrombocytopenia after bee venom therapy: a case report. BMC Complement Altern Med (2016) 0.75
DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet (2001) 10.77
The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell (1993) 7.17
The DNA-dependent protein kinase. Genes Dev (1999) 5.80
Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. EMBO J (1998) 5.79
Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell (1995) 5.58
A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature (2001) 5.28
Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science (1994) 4.99
DNA end-joining: from yeast to man. Trends Biochem Sci (1998) 4.94
DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell (1995) 4.64
Saccharomyces cerevisiae Ku70 potentiates illegitimate DNA double-strand break repair and serves as a barrier to error-prone DNA repair pathways. EMBO J (1996) 4.58
Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell (1989) 4.49
Identification of a Saccharomyces cerevisiae Ku80 homologue: roles in DNA double strand break rejoining and in telomeric maintenance. Nucleic Acids Res (1996) 4.37
Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. Curr Biol (1997) 3.67
The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms. Mol Cell (2000) 3.64
Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell (1991) 3.46
Identification of a yeast snRNP protein and detection of snRNP-snRNP interactions. Cell (1987) 3.46
Studies in Equine Encephalomyelitis: Chick Embryo Vaccine as a Protective Agent. Can J Comp Med (1938) 3.44
Identification of Saccharomyces cerevisiae DNA ligase IV: involvement in DNA double-strand break repair. EMBO J (1997) 3.29
Regulation of p53 in response to DNA damage. Oncogene (1999) 3.23
The FHA domain is a modular phosphopeptide recognition motif. Mol Cell (1999) 3.16
The TATA-binding protein: a general transcription factor in eukaryotes and archaebacteria. Science (1994) 3.06
Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature (1996) 3.04
Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol (1999) 2.98
DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? Curr Opin Cell Biol (2001) 2.93
DNA-dependent protein kinase activity is absent in xrs-6 cells: implications for site-specific recombination and DNA double-strand break repair. Proc Natl Acad Sci U S A (1995) 2.87
Menage à trois: double strand break repair, V(D)J recombination and DNA-PK. Bioessays (1995) 2.86
Preliminary Experiments Relating to the Propagation of Viruses in the Bovine Mammary Gland. Can J Comp Med Vet Sci (1953) 2.83
Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc Natl Acad Sci U S A (1996) 2.77
The yeast Xrs2 complex functions in S phase checkpoint regulation. Genes Dev (2001) 2.75
Developmental expression of Sp1 in the mouse. Mol Cell Biol (1991) 2.73
Studies in Newcastle Disease: II. Inactiated Virus and Adjuvant used as Vaccine. Can J Comp Med Vet Sci (1951) 2.58
Early Veterinary History. Can J Comp Med (1938) 2.57
Further Experiments Relating to the Propagation of Virus in the Bovine Mammary Gland. Can J Comp Med Vet Sci (1953) 2.51
DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. Proc Natl Acad Sci U S A (1991) 2.51
Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity (1998) 2.43
Buteyko breathing techniques in asthma: a blinded randomised controlled trial. Med J Aust (1999) 2.42
Protocol for emergency EPR dosimetry in fingernails. Radiat Meas (2007) 2.41
EPR dosimetry in chemically treated fingernails. Radiat Meas (2007) 2.33
Human cell senescence as a DNA damage response. Mech Ageing Dev (2005) 2.26
Mechanism and regulation of transcription in archaea. Curr Opin Microbiol (2001) 2.25
LCD1: an essential gene involved in checkpoint control and regulation of the MEC1 signalling pathway in Saccharomyces cerevisiae. EMBO J (2000) 2.22
Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr Biol (2001) 2.21
Ku, a DNA repair protein with multiple cellular functions? Mutat Res (1999) 2.16
Transcription and translation in Archaea: a mosaic of eukaryal and bacterial features. Trends Microbiol (1998) 2.08
Crystal structure of an Xrcc4-DNA ligase IV complex. Nat Struct Biol (2001) 2.07
Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation (2000) 2.04
Early Veterinary History : Sir William Osler. Can J Comp Med (1939) 2.04
Decay of influenza A viruses of human and avian origin. Can J Comp Med (1968) 2.00
Viability of Brucella Abortus Strain 19. Can J Comp Med Vet Sci (1942) 1.99
DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J (1996) 1.97
Polar overdominance at the ovine callipyge locus. Science (1996) 1.96
Conserved functional domains of the RNA polymerase III general transcription factor BRF. Genes Dev (1994) 1.90
A role for the TATA-box-binding protein component of the transcription factor IID complex as a general RNA polymerase III transcription factor. Proc Natl Acad Sci U S A (1992) 1.85
Orientation of the transcription preinitiation complex in archaea. Proc Natl Acad Sci U S A (1999) 1.84
Antibody production in milk serum after virus instillation of goat mammary gland. I. Responses to influenza virus, mumps virus, and adenovirus 3. Can J Microbiol (1967) 1.82
Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I. Development (1998) 1.81
Factor requirements for transcription in the Archaeon Sulfolobus shibatae. EMBO J (1997) 1.78
Mechanism of TATA-binding protein recruitment to a TATA-less class III promoter. Cell (1992) 1.76
Competitive and noncompetitive inhibition of the DNA-dependent protein kinase. Cancer Res (1999) 1.74
Asthma morbidity in Australia: an epidemiological study. Med J Aust (1992) 1.74
Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens. Thorax (1995) 1.72
Mapping of protein-protein interactions within the DNA-dependent protein kinase complex. Nucleic Acids Res (1999) 1.72
Sequence-specific DNA binding by the S. shibatae TFIIB homolog, TFB, and its effect on promoter strength. Mol Cell (1998) 1.71
Characterization of the residues phosphorylated in vitro by different C-terminal domain kinases. J Biol Chem (1998) 1.70
Early Veterinary History. Can J Comp Med (1939) 1.70
SV40 stimulates expression of the transacting factor Sp1 at the mRNA level. Genes Dev (1990) 1.70
Mitotic regulation of a TATA-binding-protein-containing complex. Mol Cell Biol (1995) 1.69
Exploiting the DNA repair defect in BRCA mutant cells in the design of new therapeutic strategies for cancer. Cold Spring Harb Symp Quant Biol (2005) 1.67
Aeromonas hydrophila septicemia. Am J Dis Child (1972) 1.65
DNA damage triggers disruption of telomeric silencing and Mec1p-dependent relocation of Sir3p. Curr Biol (1999) 1.64
The crystal structure of a hyperthermophilic archaeal TATA-box binding protein. J Mol Biol (1996) 1.63
Molecular and biochemical characterization of xrs mutants defective in Ku80. Mol Cell Biol (1997) 1.62
Early Veterinary History. Can J Comp Med (1939) 1.61
Asthma management in eastern Australia, 1990 and 1993. Med J Aust (1996) 1.59
Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat Genet (1999) 1.56
Electron paramagnetic resonance in human fingernails: the sponge model implication. Radiat Environ Biophys (2008) 1.55
Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain. Biochem J (1996) 1.55
A revised model of platelet aggregation. J Clin Invest (2000) 1.54
Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. Nat Genet (1997) 1.52
Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene (1996) 1.52
Lif1p targets the DNA ligase Lig4p to sites of DNA double-strand breaks. Curr Biol (2000) 1.51
Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc Natl Acad Sci U S A (1999) 1.50
Extraordinary sequence conservation of the PRP8 splicing factor. Yeast (1995) 1.50
Isolation and characterization of thrombomodulin from human placenta. J Biol Chem (1984) 1.50
Audit of consultant physicians' reply letters for referrals to clinics in a tertiary teaching hospital. Intern Med J (2004) 1.49
Identification of bacterial homologues of the Ku DNA repair proteins. FEBS Lett (2001) 1.49
The TATA-binding protein: a central role in transcription by RNA polymerases I, II and III. Trends Genet (1992) 1.47
Patient attitudes to sternotomy and thoracotomy scars. Thorac Cardiovasc Surg (2005) 1.47
Vaccination of Sexually Mature Cows with Brucella abortus Strain 19: I. Negative Cows Contained in Negative Dairy Herds. Can J Comp Med Vet Sci (1948) 1.46
A national policy on asthma management for schools. The Asthma Special Interest Group, Thoracic Society of Australia and New Zealand. J Paediatr Child Health (1994) 1.45
Cell cycle regulation of RNA polymerase III transcription. Mol Cell Biol (1995) 1.44
Immune thrombocytopenia in association with acute lymphoblastic leukaemia and a haemophagocytic syndrome. Eur J Haematol (1993) 1.44
The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53. Oncogene (1999) 1.41
Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. EMBO J (1997) 1.41
Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol (1994) 1.40
Studies in Newcastle Disease: III. Production of a Hyperimmune Serum in a Horse. Can J Comp Med Vet Sci (1951) 1.39
Infectious Anaemia and Encephalomyelitis Vaccination. Can J Comp Med Vet Sci (1943) 1.39
Development of a program to manage costly outliers. Clin Nurse Spec (2001) 1.39